NSEESOP/ESOS/ESPS26 Jun 2026 · 26 Jun 2026, 12:31 pm
ESOP/ESOS/ESPS
Eris Lifesciences Limited · ERIS
✦ AI Summaryesop
Eris Lifesciences Limited has informed the Exchange regarding the allotment of 11,233 equity shares pursuant to the exercise of options under the ESOP Scheme, increasing the paid-up share capital from ₹13,85,67,256 to ₹13,85,78,489.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Limited has informed the Exchange regarding Allotment of 11233 Shares.
Attachments (1)
📄pdf
Download →
ERIS_26062026123109_Intimationsigned.pdf
View document text
Date: 26 June 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai – 400001 Bandra (E)
Mumbai – 400051
Security Code: 540596 Symbol: ERIS
Dear Sir/Madam,
SUB: ALLOTMENT OF EQUITY SHARES PURSUANT TO ESOP-2021 SCHEME
It is hereby informed that an allotment of 11,233 equity shares has been made on June 26, 2026, pursuant to
exercise of options under the ESOP Scheme. Further details are tabulated below:
ESOP Scheme Year of Grant No. of equity shares allotted Issue price per share
2022 3,401 Rs. 557.24/-
ESOP-2021 Scheme 2023 3,662 Rs. 510.32/-
2024 4,170 Rs. 728.16/-
The paid-up share capital of the Company accordingly stands increased from ₹13,85,67,256/- (13,85,67,256
equity shares of ₹1/- each) to ₹13,85,78,489/- (13,85,78,489 equity shares of ₹1/- each).
The Information may please be taken on records.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
ICSI Mem. No.: A26493